Evidence map›Paper›PMID 10846090›Full record

ArticleJournal of virology2000

Epstein-Barr virus EB2 protein exports unspliced RNA via a Crm-1-independent pathway.

G Farjot, M Buisson, M Duc Dodon, L Gazzolo, A Sergeant, I Mikaelian

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

G FarjotU412 INSERM, ENS-Lyon, France.
M Buisson
M Duc Dodon
L Gazzolo
A Sergeant
I Mikaelian
École Normale Supérieure de Lyon · FRInserm · FRLaboratoire de Biologie et Modélisation de la Cellule · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human herpesviruses encode posttranscriptional activators that are believed to up-regulate viral replication by facilitating early and late gene expression. We have reported previously that the Epstein-Barr virus protein EB2 (also called M or SM) promotes nuclear export of RNAs that are poor substrates for spliceosome assembly, an effect that closely resembles the human immunodeficiency virus type 1 Rev-dependent nuclear export of unspliced viral RNA. Here we present experimental data showing that EB2 efficiently promotes the nuclear export of unspliced RNA expressed from a Rev reporter construct. Site-directed mutagenesis as well as domain swapping experiments indicate that a leucine-rich region found in the EB2 protein, which matches the consensus sequence for the leucine-rich nuclear export signal, is not a nuclear export signal per se. Accordingly, leptomycin B (LMB), a specific Crm-1 inhibitor, impairs Rev- but not EB2-dependent nuclear export of unspliced RNA. Moreover, EB2 nucleocytoplasmic shuttling visualized by a heterokaryon assay is, unlike Rev shuttling, not affected by LMB. We also show that overexpression of an N-terminal deletion mutant of Nup214/can, a major nucleoporin of the nuclear pore complex involved in several aspects of nuclear transport, blocks both Rev- and EB2-dependent nuclear export of RNA. These results strongly suggest that EB2 nuclear export of unspliced RNA is mediated by a Crm-1-independent pathway.

Indexed as

KaryopherinsNuclear Pore Complex ProteinsReceptors, Cytoplasmic and NuclearRNA Splicing3T3 CellsAnimalsBiological TransportCarrier ProteinsCell NucleusCytoplasmDrug ResistanceExportin 1 ProteinFatty Acids, UnsaturatedGene Products, revHeLa CellsHerpesvirus 4, HumanBRLF1 protein, Human herpesvirus 4Carrier ProteinsExportin 1 ProteinFatty Acids, UnsaturatedGene Products, revImmediate-Early ProteinsKaryopherinsleptomycin BLeucineNuclear Pore Complex ProteinsNuclear ProteinsNUP214 protein, humanNup214 protein, mouseReceptors, Cytoplasmic and Nuclearrev Gene Products, Human Immunodeficiency VirusTrans-ActivatorsViral Proteins

Identifiers

PMID10846090
PMCPMC112105
OpenAlexW2075057886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.